Cardurion Pharmaceuticals Announces Investment of up to $300 Million from Bain Capital
Investment to support Cardurion’s further evolution into a cardiovascular leader BOSTON – October 27, 2021 – Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced it has received a private investment […]
